Tajinder Vohra
Net Worth

Last updated:

What is Tajinder Vohra net worth?

The estimated net worth of Mr. Tajinder Vohra is at least $5,130,940 as of 22 Dec 2022. He has earned $930,940 from insider trading and has received compensation worth at least $4,200,000 in PerkinElmer, Inc..

What is the salary of Tajinder Vohra?

Mr. Tajinder Vohra salary is $1,400,000 per year as Senior Vice President of Global Operations in PerkinElmer, Inc..

How old is Tajinder Vohra?

Mr. Tajinder Vohra is 59 years old, born in 1966.

What stocks does Tajinder Vohra currently own?

As insider, Mr. Tajinder Vohra owns shares in one company:

Company Title Shares Price per share Total value
PerkinElmer, Inc. (PKI) Senior Vice President of Global Operations 17,205 $0 $0

What does PerkinElmer, Inc. do?

PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

Tajinder Vohra insider trading

PerkinElmer, Inc.

Mr. Tajinder Vohra has made 11 insider trades in 2022, according to the Form 4 filled with the SEC. Most recently he sold 410 units of PKI stock worth $57,861 on 22 Dec 2022.

The largest trade he's ever made was exercising 1,663 units of PKI stock on 20 Dec 2022. As of 22 Dec 2022 he still owns at least 17,205 units of PKI stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 410 $141.12 $57,861
Sale
Common Stock 673 $140.37 $94,470
Option
Common Stock 1,663 $48.98 $81,445
Sale
Common Stock 580 $139.21 $80,739
Option
NQ Stock Option (right to buy) 1,663 $48.98 $81,445
Option
Common Stock 1,662 $48.98 $81,396
Sale
Common Stock 712 $142.5 $101,460
Sale
Common Stock 362 $140.57 $50,885
Sale
Common Stock 588 $143.47 $84,358
Option
NQ Stock Option (right to buy) 1,662 $48.98 $81,396
Sale
Common Stock 90 $136.96 $12,326
Option
NQ Stock Option (right to buy) 1,663 $48.98 $81,445
Option
Common Stock 1,663 $48.98 $81,445
Sale
Common Stock 941 $139.26 $131,039
Sale
Common Stock 632 $138.51 $87,536
Option
NQ Stock Option (right to buy) 1,662 $48.98 $81,396
Sale
Common Stock 761 $139.04 $105,809
Option
Common Stock 1,662 $48.98 $81,396
Sale
Common Stock 901 $138.13 $124,455

PerkinElmer key executives

PerkinElmer, Inc. executives and other stock owners filed with the SEC: